All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

/images/Cortellis_Flagship_Logo_TM_RGB_Color.png
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Artificial intelligence
    • Coronavirus
    • Diagnosing and tracking COVID-19
    • Drugs to Watch 2020
    • The next pandemic
    • Premium reports
      • BioWorld Financings Reports
      • Disease Forecast Reports

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, February 27, 2021
Home » Blogs » BioWorld Perspectives » An end to Charlotte’s web?

BioWorld Perspectives
BioWorld Perspectives RSS FeedRSS

BioWorld

An end to Charlotte’s web?

May 10, 2016
By Mari Serebrov
No Comments

Wilbur blogIn the annals of popular literature, TV shows and movie scripts, only a handful of pigs have achieved mega stardom: Napoleon, who took over a farm and assassinated his political rivals; Arnold, who epitomized the couch potato at Green Acres; Miss Piggy, who used her feminine wiles and street smarts to become the piglet diva of the Muppets; Babe, who used his sheep-herding skills to survive and land a starring role in a movie; and Wilbur, who had the best ad agent of them all.

While other famous pigs were almost human in their aspirations and lifestyle, Wilbur was, well, just a pig. He lived in the farmyard with the other animals. He liked dozing in the sun, rolling in the mud, getting his ears scratched. Yep, give him a pig’s life any day!

That was the catch. He wanted a pig’s life – not a pig’s death. Wilbur’s fear of his destiny is what set him apart from the other pigs in the pen. That and his friendship with Charlotte, the arachnid answer to Madison Avenue.

While Wilbur was just like any other pig, Charlotte’s marketing campaign declared that he was "SOME PIG!" And her campaign at the county fair created the buzz that gave Wilbur a perceived value beyond his weight in ham.

As a result, Wilbur’s story had a happy ending. For him. He got to live out his life surrounded by his friends. Of course, the farmer had to eat the cost of taking care of a big hog that did nothing but dozed in the sun, rolled around in the mud, begged to get his ears scratched and pigged out at the farmyard trough.

The story was a bit different for Babe, the other porcine hero who escaped the butcher knife by becoming a county fair celebrity. Unlike Wilbur whose claim to fame was all in Charlotte’s web, Babe earned his keep by developing a skill that brought true value to the farmer and the sheep he guarded.

Just as Charlotte did for Wilbur, some drug companies want to save their bacon by trying to make their run-of-the-farmyard pills look spectacular. They find a Charlotte to spin webs proclaiming the wonders of their drug to the market, hoping to make their product stand out as truly “TERRIFIC” or “RADIANT.” As the perceived value goes up, so does the price.

But with a farmyard trough that can’t keep up with the voracious appetite of too many Wilburs, the fairgoers are starting to demand real value and an end to the web spinning. Today, it’s not enough to proclaim “SOME PILL!” To keep their high prices, drugs have to rise above the pigs in the farmyard by delivering real value to more than their investors.

Sorry, Wilbur. Your days may be numbered.

You must login or register in order to post a comment.

Report Abusive Comment

Popular Stories

  • Free access to BioWorld coronavirus articles

    BioWorld

    The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus outbreak. Note that we have added three critical tables which are...

  • Seniors with wooden puzzle

    Cassava’s simufilam improves AD patients’ cognition, behavior

    BioWorld
    When Cassava Sciences Inc.’s president and CEO, Remi Barbier, opened up the interim analysis of the company’s open-label study for Alzheimer’s disease candidate...
  • Vaxart COVID-19 vaccine tablets

    Vaxart shares shaken despite apparently positive early data for oral COVID-19 vaccine

    BioWorld
    Vaxart Inc. investors who stuck by company shares Feb. 3 had to swallow a bitter pill – watching shares of the oral vaccine developer (NASDAQ:VXRT) fall 57.8% to...
  • IPO money

    Lucira Health launches $153M IPO

    BioWorld MedTech
    Infectious diseases diagnostics company Lucira Health Inc. launched an IPO of 9 million shares of common stock at $17 per share, for expected gross proceeds of...
  • Today's news in brief

    BioWorld
    BioWorld briefs for Feb. 26.
cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • About
    • Archives
    • Today's news
    • Search BioWorld Science
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
A Clarivate Analytic solution. Link to Clarivate website.
Follow Us

Copyright ©2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing